Hyperion Imaging & Intervention Limited 14624240 false 2024-02-01 2025-01-31 2025-01-31 The principal activity of the company is Specialised medical activities Digita Accounts Production Advanced 6.30.9574.0 true 14624240 2024-02-01 2025-01-31 14624240 2025-01-31 14624240 core:RetainedEarningsAccumulatedLosses 2025-01-31 14624240 core:ShareCapital 2025-01-31 14624240 core:CurrentFinancialInstruments 2025-01-31 14624240 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 14624240 core:FurnitureFittingsToolsEquipment 2025-01-31 14624240 bus:SmallEntities 2024-02-01 2025-01-31 14624240 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 14624240 bus:FilletedAccounts 2024-02-01 2025-01-31 14624240 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 14624240 bus:RegisteredOffice 2024-02-01 2025-01-31 14624240 bus:Director1 2024-02-01 2025-01-31 14624240 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 14624240 core:FurnitureFittingsToolsEquipment 2024-02-01 2025-01-31 14624240 core:OtherRelatedParties 2024-02-01 2025-01-31 14624240 countries:AllCountries 2024-02-01 2025-01-31 14624240 2023-01-30 2024-01-31 14624240 2024-01-31 14624240 core:RetainedEarningsAccumulatedLosses 2024-01-31 14624240 core:ShareCapital 2024-01-31 14624240 core:CurrentFinancialInstruments 2024-01-31 14624240 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 iso4217:GBP xbrli:pure

Registration number: 14624240

Hyperion Imaging & Intervention Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 January 2025

 

Hyperion Imaging & Intervention Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 6

 

Hyperion Imaging & Intervention Limited

Company Information

Director

Dr A Smith

Registered office

c/o Kingfisher Court
Plaxton Bridge Road
Woodmansey
Beverley
HU17 0RT

 

Hyperion Imaging & Intervention Limited

(Registration number: 14624240)
Balance Sheet as at 31 January 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

6,740

-

Current assets

 

Debtors

5

1,203

1,082

Cash at bank and in hand

 

21,280

10,264

 

22,483

11,346

Creditors: Amounts falling due within one year

6

(5,735)

(3,322)

Net current assets

 

16,748

8,024

Total assets less current liabilities

 

23,488

8,024

Provisions for liabilities

(1,281)

-

Net assets

 

22,207

8,024

Capital and reserves

 

Called up share capital

3

3

Retained earnings

22,204

8,021

Shareholders' funds

 

22,207

8,024

For the financial year ending 31 January 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the Company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The Director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the Director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 28 April 2025
 

.........................................
Dr A Smith
Director

 

Hyperion Imaging & Intervention Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

1

General information

The Company is a private company limited by share capital, incorporated in England and Wales .

The address of its registered office is:
c/o Kingfisher Court
Plaxton Bridge Road
Woodmansey
Beverley
HU17 0RT

The principal place of business is:
7 Highcroft
Cherry Burton
Beverley
HU17 7SG

These financial statements were authorised for issue by the director on 28 April 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements have been prepared in sterling and are rounded to the nearest pound.

Revenue recognition

Turnover arises from the provision of medical services. Turnover is measured at the fair value of the consideration received or receivable and represents amounts for the rendering of services in the normal course of business, net of discounts and other sales-related taxes.

Turnover from the provision of services is recognised when the service is performed.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met of each of the companies activities.

 

Hyperion Imaging & Intervention Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the Company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the Company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Hyperion Imaging & Intervention Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

3

Staff numbers

The average number of persons employed by the Company (including the Director) during the year, was 1 (2024 - 1).

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

Additions

7,711

7,711

At 31 January 2025

7,711

7,711

Depreciation

Charge for the year

971

971

At 31 January 2025

971

971

Carrying amount

At 31 January 2025

6,740

6,740

5

Debtors

2025
£

2024
£

Other debtors

1,203

1,082

1,203

1,082

6

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

7

500

-

Taxation and social security

 

3,724

1,882

Accruals and deferred income

 

1,511

1,440

 

5,735

3,322

 

Hyperion Imaging & Intervention Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

7

Loans and borrowings

Current loans and borrowings

2025
£

2024
£

Other borrowings

500

-

Included in other borrowings are unsecured amounts due to the Director.

8

Related party transactions

Transactions with the Director

Other transactions with the Director

At the year end the company owed the director £501 (2024: £(78)). Loans made to the director by the company are unsecured, interest free and repayable on demand.

Summary of transactions with other related parties

D Smith (Shareholder)

At the year end, D Smith owed the Company £1,000 (2024: £1,000) in respect of a shareholder loan balance. The amount is unsecured, interest-free and repayable on demand.